These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
4. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions. Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733 [TBL] [Abstract][Full Text] [Related]
5. Design and lyophilization of mRNA-encapsulating lipid nanoparticles. Wang T; Yu T; Li W; Liu Q; Sung TC; Higuchi A Int J Pharm; 2024 Sep; 662():124514. PubMed ID: 39067550 [TBL] [Abstract][Full Text] [Related]
6. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles. Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135 [TBL] [Abstract][Full Text] [Related]
8. Payload distribution and capacity of mRNA lipid nanoparticles. Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112 [TBL] [Abstract][Full Text] [Related]
9. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length. Mrksich K; Padilla MS; Joseph RA; Han EL; Kim D; Palanki R; Xu J; Mitchell MJ J Biomed Mater Res A; 2024 Sep; 112(9):1494-1505. PubMed ID: 38487970 [TBL] [Abstract][Full Text] [Related]
10. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA. Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923 [TBL] [Abstract][Full Text] [Related]
11. Elucidation of lipid nanoparticle surface structure in mRNA vaccines. Wang MM; Wappelhorst CN; Jensen EL; Chi YT; Rouse JC; Zou Q Sci Rep; 2023 Oct; 13(1):16744. PubMed ID: 37798336 [TBL] [Abstract][Full Text] [Related]
12. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform. Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139 [TBL] [Abstract][Full Text] [Related]
13. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA. Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764 [TBL] [Abstract][Full Text] [Related]
14. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174 [TBL] [Abstract][Full Text] [Related]